Components:
Medically reviewed by Oliinyk Elizabeth Ivanovna, PharmD. Last updated on 21.04.2022
Attention! Information on this page is intended only for medical professionals! Information is collected in open sources and may contain significant errors! Be careful and double-check all the information on this page!
Top 20 medicines with the same components:
Improvement of memory, concentration and mental alertness.
Prevention of further degeneration of cognitive function, social functioning ability and depressive mood associated with dementia syndromes eg, Alzheimer's and vascular dementia. Tinnitus, vertigo, peripheral arterial occlusive disease, improves blood circulation.
Note: Prior to starting treatment with Ginkgo extract, clarification should be obtained as to whether the pathological symptoms encountered are not based on an underlying disease requiring a specific treatment.
Improvement of the pain-free walking distance in peripheral arterial occlusive disease in Fontaine stage II (intermittent claudication) within the framework of physical therapeutic measures, in particular walking training.
Vertigo of vascular and involutional origin.
Adjuvant treatment in case of tinnitus of vascular and involutional origin.
Frequently occurring dizziness and tinnitus always need to be clarified by a physician.
In case of sudden hearing deficit or hearing loss, patient should immediately consult a physician.
Circulation and memory loss due to brain conditions such as stroke, Alzheimer disease, and dementia. It may also have other uses. Check with your pharmacist for more details regarding the particular brand you use.
Tebofortin is an herbal product. It works by increasing blood flow to the brain.
Normal
Dosage: 1 tab daily. For more intensive use, 1 tab may be taken twice daily. The intake of Tebofortin is independent of meals.
See also:
What is the most important information I should know about Tebofortin?
Hypersensitivity to Tebofortin or to any of the excipients of Tebofortin.
Use in lactation: It is unknown whether Tebofortin/metabolites are excreted in human milk. A risk to the newborns/infants cannot be excluded. Tebofortin should not be used during breastfeeding.
Use Tebofortin as directed by your doctor. Check the label on the medicine for exact dosing instructions.
- Dosing depends on the use and the source of the product.
- Use as directed on the package, unless instructed otherwise by your doctor.
- If you miss taking a dose of Tebofortin for 1 or more days, there is no cause for concern. If your doctor recommended that you take it, try to remember your dose every day.
Ask your health care provider any questions you may have about how to use Tebofortin.
There are specific as well as general uses of a drug or medicine. A medicine can be used to prevent a disease, treat a disease over a period or cure a disease. It can also be used to treat the particular symptom of the disease. The drug use depends on the form the patient takes it. It may be more useful in injection form or sometimes in tablet form. The drug can be used for a single troubling symptom or a life-threatening condition. While some medications can be stopped after few days, some drugs need to be continued for prolonged period to get the benefit from it.Cerebrovascular and peripheral activator, dementia.
In case of simultaneous application of Tebofortin with coagulation-inhibiting drugs (eg, phenprocoumon, warfarin, clopidogrel, acetylsalicylic acid and other nonsteroidal antirheumatics) it cannot be excluded that the effect of these medicines are enhanced.
As for all medicinal preparations, it cannot be excluded that Tebofortin acts on the metabolization of other different medicinal preparations which may influence the potency and/or duration of the effect of the preparation concerned. There are no sufficient investigations available on these effects. Inform the physician if administering or have recently taken any other medicines including medicines obtained without prescription.
See also:
What are the possible side effects of Tebofortin?
There are no verified data on the frequency of the undesirable effects observed during treatment with Tebofortin-containing preparations, since these adverse effects have become known through single reports from patients, physicians or pharmacists. According to these reports, the following side effects may occur during treatment with Tebofortin: Nervous System Disorders: Headache.
Vascular Disorders: Bleeding from single organs has been reported.
Gastrointestinal Disorders: Mild gastrointestinal disturbances.
Skin and Subcutaneous Tissue Disorders: Allergic skin reactions (reddening, swelling, itching).
Each film-coated tablet contains EGb 761® [dry extract from Tebofortin leaves (35-67:1)]; Extraction Agent: Acetone 60% (m/m).
The extract in each film-coated tablet is quantified to flavonoids 26.4-32.4 mg, calculated as flavone glycosides, and terpene lactones 6.48-7.92 mg of which gingkgolides A, B, C 3.36-4.08 mg as well as bilobalide 3.12-3.84 mg, and contains ginkgolic acids <0.6 mcg.
Tebofortin also contains the following excipients: Croscarmellose sodium, colloidal silica; hypromellose, lactose monohydrate, macrogol 1500; magnesium stearate; maize starch, microcrystalline cellulose, dimethicone, α-octadecyl-ω-hydroxypoly(oxyethylene)-5; talcum; titanium dioxide E171; iron oxide E172.